JPMORGAN CHASE & CO - CANTEL MEDICAL CORP ownership

CANTEL MEDICAL CORP's ticker is CMD and the CUSIP is 138098108. A total of 214 filers reported holding CANTEL MEDICAL CORP in Q2 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.3%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of CANTEL MEDICAL CORP
ValueSharesWeighting
Q1 2021$149,491,000
+21.5%
1,872,392
+20.1%
0.02%
+11.1%
Q4 2020$122,988,000
+116.9%
1,559,578
+22.9%
0.02%
+80.0%
Q3 2020$56,704,000
+3031.1%
1,269,394
+3002.4%
0.01%
Q2 2020$1,811,000
-10.0%
40,917
-27.0%
0.00%
Q1 2020$2,012,000
-50.1%
56,044
-1.4%
0.00%
-100.0%
Q4 2019$4,030,000
-7.9%
56,847
-2.9%
0.00%0.0%
Q3 2019$4,376,000
+29.1%
58,517
+33.8%
0.00%0.0%
Q2 2019$3,390,000
-3.6%
43,719
-16.8%
0.00%0.0%
Q1 2019$3,516,000
-37.4%
52,574
-30.3%
0.00%0.0%
Q4 2018$5,619,000
-22.3%
75,479
-3.9%
0.00%0.0%
Q3 2018$7,229,000
-59.7%
78,529
-56.9%
0.00%
-75.0%
Q2 2018$17,931,000
+151.9%
182,299
+185.3%
0.00%
+100.0%
Q1 2018$7,119,000
-32.8%
63,895
-37.9%
0.00%0.0%
Q4 2017$10,588,000
+210.7%
102,938
+174.6%
0.00%
+100.0%
Q3 2017$3,408,000
+48.0%
37,480
+26.8%
0.00%0.0%
Q2 2017$2,303,000
-51.6%
29,563
-50.3%
0.00%0.0%
Q1 2017$4,762,000
-46.9%
59,451
-47.8%
0.00%
-50.0%
Q4 2016$8,974,000
+299.0%
113,954
+295.1%
0.00%
+100.0%
Q3 2016$2,249,000
+3307.6%
28,840
+2885.5%
0.00%
Q2 2016$66,000
+340.0%
966
+373.5%
0.00%
Q1 2016$15,000
+25.0%
204
+6.8%
0.00%
Q4 2015$12,000
-99.1%
191
-99.5%
0.00%
Q4 2013$1,357,000
+13.1%
40,008
+6.2%
0.00%
Q3 2013$1,200,000
+3.0%
37,658
+9.5%
0.00%
Q2 2013$1,165,00034,3900.00%
Other shareholders
CANTEL MEDICAL CORP shareholders Q2 2020
NameSharesValueWeighting ↓
IFP Advisors, Inc 0$00.00%
View complete list of CANTEL MEDICAL CORP shareholders